Wolverine Asset Management’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-14,500
Closed -$22K 2038
2022
Q4
$22K Hold
14,500
﹤0.01% 1510
2022
Q3
$30K Hold
14,500
﹤0.01% 1727
2022
Q2
$19K Sell
14,500
-4,200
-22% -$6.23K ﹤0.01% 1851
2022
Q1
$39K Sell
18,700
-124,500
-87% -$303K ﹤0.01% 1591
2021
Q4
$531K Buy
143,200
+100
+0.1% +$430 ﹤0.01% 997
2021
Q3
$714K Sell
143,100
-24,900
-15% -$143K 0.01% 859
2021
Q2
$1.09M Hold
168,000
0.01% 608
2021
Q1
$1.16M Sell
168,000
-23,500
-12% -$199K 0.01% 588
2020
Q4
$1.95M Buy
191,500
+23,700
+14% +$154K 0.01% 461
2020
Q3
$587K Buy
167,800
+41,000
+32% +$195K 0.01% 699
2020
Q2
$632K Sell
126,800
-10,800
-8% -$36.7K 0.01% 667
2020
Q1
$467K Sell
137,600
-198,400
-59% -$856K 0.01% 698
2019
Q4
$1.84M Sell
336,000
-125,300
-27% -$705K 0.02% 460
2019
Q3
$2.64M Sell
461,300
-13,600
-3% -$92.4K 0.03% 347
2019
Q2
$3.64M Buy
474,900
+236,800
+99% +$1.27M 0.05% 300
2019
Q1
$1.25M Sell
238,100
-19,900
-8% -$138K 0.02% 585
2018
Q4
$1.69M Buy
258,000
+28,300
+12% +$317K 0.02% 612
2018
Q3
$3.96M Buy
+229,700
New +$3.42M 0.05% 361

Other funds holding PGEN

Wolverine Asset Management's PGEN Position: Q1 2023 in Review

Wolverine Asset Management sold out of Precigen (PGEN) in Q1 2023, closing a stake of 140,887 shares — an estimated $214K sold.

Wolverine Asset Management first reported a position in PGEN in Q3 2022 and held it in 2 quarters. The position peaked at $214K in Q4 2022. 157 funds tracked by Wall St. Rank hold PGEN as of Q1 2023.

  • Wolverine Asset Management reported no remaining Precigen position as of Q1 2023 after selling out during the quarter.
  • Wolverine Asset Management sold 140,887 Precigen shares in Q1 2023, an estimated $214K.
  • Wolverine Asset Management first reported a position in Precigen in Q3 2022 and held it in 2 quarters.
  • Wolverine Asset Management's Precigen position peaked at $214K in Q4 2022.
  • 157 funds tracked by Wall St. Rank held Precigen as of Q1 2023.

Based on Wolverine Asset Management's 13F filing for Q1 2023, filed 8 May 2023.